Review of Pharmacologic Considerations in the Use of Azole Antifungals in Lung Transplant Recipients.

In addition, posaconazole has a half-life of ≥24 h [ 79 ], so that while there may not be significant variability at steady-state within an every 6- to 8- hour suspension dosing regimen, variability will be more pronounced within the tablet 24 h interval.

also in 2,774 other papers